Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Lisa M Kalisch Ellett

Biographic Data

ID2056744
NAMELisa M Kalisch Ellett
GIVEN NAMESLisa M Kalisch
FAMILY NAMEEllett
SIGNATUREELLETT L M K
AFFILIATIONSUniversity of South Australia
ORCID0000-0001-5063-6128
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2015
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Impact of antiretroviral shortages in HIV therapy and prevention uptake in Australia

    Chieu-Hoang Ly Luong, Lisa M Kalisch Ellett et al.•ARTICLE•AIDS Care•2026

    Human immunodeficiency virus (HIV) remains a major public health priority in Australia, with treatment and prevention efforts underpinned by access to government-subsidised antiretroviral therapy (ART) through the Pharmaceutical Benefits Scheme (PBS). In 2023-2024, multiple tenofovir with emtricitabine products used for HIV treatment and pre-exposure prophylaxis (PrEP) were subject to national shortages, raising concerns about access and continui…

  • Use of analgesics following rescheduling of codeine in Australia

    Open Access•Lisa M Kalisch Ellett, Anna Kemp et al.•ARTICLE•International Journal of Drug…•2020

  • Commitment questions targeting patients promotes uptake of under-used health services

    Open Access•Nicole L Pratt, Nicole Pratt et al.•ARTICLE•Social Science & Medicine•2015•References: 26

No prominent works on this page.

  • Commitment questions targeting patients promotes uptake of under-used health services

    Open Access•Nicole L Pratt, Nicole Pratt et al.•ARTICLE•Social Science & Medicine•2015•References: 26

  • Use of analgesics following rescheduling of codeine in Australia

    Open Access•Lisa M Kalisch Ellett, Anna Kemp et al.•ARTICLE•International Journal of Drug…•2020

  • Impact of antiretroviral shortages in HIV therapy and prevention uptake in Australia

    Chieu-Hoang Ly Luong, Lisa M Kalisch Ellett et al.•ARTICLE•AIDS Care•2026

    Human immunodeficiency virus (HIV) remains a major public health priority in Australia, with treatment and prevention efforts underpinned by access to government-subsidised antiretroviral therapy (ART) through the Pharmaceutical Benefits Scheme (PBS). In 2023-2024, multiple tenofovir with emtricitabine products used for HIV treatment and pre-exposure prophylaxis (PrEP) were subject to national shortages, raising concerns about access and continui…

Medicine (2 works) · Anesthesia (1 work) · Antiretroviral therapy (1 work) · Biology (1 work) · Codeine (1 work) · Confidence interval (1 work) · Economic shortage (1 work) · Emtricitabine (1 work) · Environmental health (1 work) · Family medicine (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae